A 59-year-old with recurrent CDI after two standard courses of vancomycin remains high risk for recurrence and is not a transplant candidate. Which pr...

Question

A 59-year-old with recurrent CDI after two standard courses of vancomycin remains high risk for recurrence and is not a transplant candidate. Which preferred therapy?

Accepted Answer

Fidaxomicin (standard or extended-pulsed)

Answer

Repeat metronidazole

Answer

Probiotics alone

Answer

Stop antibiotics and monitor

Answer

Rifaximin monotherapy

us-abim MCQ (SBA): Refractory/Recurrent CDI

A 59-year-old with recurrent CDI after two standard courses of vancomycin remains high risk for recurrence and is not a transplant candidate. Which preferred therapy?